| Overview |
| bsm-63059r-cy5-100ul |
| phospho-BAD (S75) Recombinant Antibody, Cy5 Conjugated |
| WB |
| Human |
| Mouse, Rat |
| Specifications |
| Cy5 |
| Rabbit |
| KLH conjugated Synthesised phosphopeptide derived from human BAD around the phosphorylation site of Ser75 |
| Recombinant |
| IgG |
| Lot Dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 572 |
| Q92934 |
| Cytoplasm, Cell membrane |
| Bad (phospho S75); Bad (phospho Ser75); p-Bad (S75);p- Bad (Ser75); p-Bad (phospho Ser75); BBC 2; BBC2; BBC6; Bcl 2 Antagonist of Cell Death; Bcl 2 Binding Component 6; BCL X / BCL 2 Binding Protein; BCL X Binding Protein; Bcl XL/Bcl 2 Associated Death Promoter; Bcl-2-like protein 8; Bcl2 antagonist of cell death; BCL2 antagonist of cell death protein; BCL2 associated agonist of cell death; Bcl2 Associated Death Promoter; BCL2 binding component 6; BCL2 binding protein; Bcl2 Like 8 Protein; Bcl2-L-8; BCL2L8; BclXL; Proapoptotic BH3 Only Protein; BAD_HUMAN; Bcl-2-binding component 6. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz